ORAMED PHARMACEUTICALS INC.

ORMP · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.2B · 13 employees
381
SEC Filings
$3.89
Close 2026-06-01
13
Employees

Business Summary

and Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations, as well as elsewhere in this Annual Report on Form 10-K and include, among other statements, statements regarding the following: our plan to evaluate potential strategic opportunities; our potential repurchases of shares of our common stock; our ability to recover the proceeds and/or collateral under the Tranche A Note and Tranche B Note(as defined herein) and related agreements from Scilex Holding ...

Latest Stock Quote

ORMP 2026-06-01 $3.89 O:$3.93 H:$4.02 L:$3.8 Vol:0.2M VWAP:$3.9203
origin leaf: 4c782d9174420305d9024291c46707be74e6f743f2cdabaef31fbd8679c476c3

Next Earnings

Q2 FY2026 — expected 2026-08-21

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001213900-26-034835EDGAR78K words
2025-03-272024-12-310001013762-25-003450EDGAR—
2024-03-062023-12-310001213900-24-020485EDGAR—
2023-03-062022-12-310001213900-23-017837EDGAR—
2021-11-242021-08-310001213900-21-062009EDGAR—
2020-11-242020-08-310001213900-20-038924EDGAR—
2019-11-272019-08-310001213900-19-024940EDGAR—
2018-11-282018-08-310001213900-18-016666EDGAR—
2017-11-292017-08-310001213900-17-012754EDGAR—
2016-11-252016-08-310001213900-16-018954EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001213900-25-109980EDGAR27K words
2025-08-142025-06-300001213900-25-076668EDGAR—
2025-05-152025-03-310001213900-25-044193EDGAR—
2024-11-072024-09-300001213900-24-095397EDGAR—
2024-08-142024-06-300001213900-24-068992EDGAR—
2024-05-092024-03-310001213900-24-041364EDGAR—
2023-11-092023-09-300001213900-23-085310EDGAR—
2023-08-102023-06-300001213900-23-065678EDGAR—
2023-05-112023-03-310001213900-23-038593EDGAR—
2022-11-102022-09-300001213900-22-071222EDGAR—
2022-08-102022-06-300001213900-22-046399EDGAR—
2022-05-122022-03-310001213900-22-026004EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001213900-26-037474EDGAR1K words
2026-02-200001012975-26-000195EDGAR—
2026-01-140001213900-26-004382EDGAR—
2026-01-070001213900-26-001983EDGAR—
2025-12-310001213900-25-127133EDGAR—
2025-12-310001012975-25-000992EDGAR—
2025-11-170001213900-25-111310EDGAR—
2025-11-170001213900-25-111298EDGAR—
2025-10-240001213900-25-101825EDGAR—
2025-10-060001213900-25-096322EDGAR—

381 total filings indexed. 349 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001176309
TickerORMP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.oramed.com
Listed2004-04-19

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d84bd90a0b5b3e1049f9f8b91e02da26126add9fe699257995821dd55e7a8d7e
parent: b050098fd940f67033637c1206b3d5515e3f430220a596e7869eae5012560cda
content hash: 55cefa9ab2f01a3a8efc404d8b4873ac2039dc279e08a0616fbacfac278cd853
signed: 2026-06-02T19:02:11.745Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf